Patents

Patent	Issued	Patent ID
Methods for Objective Assessment of Memory, Early Detection of Risk for Alzheimer‘s Disease, Matching Individuals with Treatments, Monitoring Response to Treatments, and New Methods for Use for Drugs.	03-10-2026	US-12,569,483-B2
Methods for Objective Assessment of Stress, Early Detection of Risk for Stress Disorders, Matching Individuals with Treatments, Monitoring Response to Treatment, and New Methods of Use for Drugs.	01-20-2026	US-12,529,704-B2
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Australia)	09-04-2025	AU 2019235923
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Europe)	10-30-2024	EP 3307910
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Europe)	08-27-2024	EP 3765630
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Japan)	05-20-2024	JP 7491847B2
Precision Medicine for Treating and Preventing Suicidality	03-21-2023	US-11,608,532-B2
Drugs, Pharmacogenomics and Biomarkers for Active Longevity	08-06-2022	EP 3 433 380 B1
Blood Biomarkers for Suicidality	06-29-2021	US-11,047,009-B2
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment	04-27-2021	US-10,991,449-B2
Precision Medicine for Pain; Diagnostic Biomarkers, Pharmacogenomics, and Repurposed Drugs (Israel)	Notice of Allowance	IL 277000
Predicting Suicidality Using A Combined Genomic and Clinical Risk Assessment (Canada)	Notice of Allowance	CA 2988578

A series of other patents are pending in various jurisdictions.